2026 NASCI Annual Meeting
September 26-29, 2026
Westin Denver Downtown
Denver, CO
Submission Deadline: Sunday, May 3, 2026 – 11:59 PM Eastern Time
- All abstracts must be submitted through the online abstract submission process.
- Deadline for Submission: Sunday, May 3, 2026, at 11:59 pm Eastern Time
- Presenters must be members of NASCI and must register for and attend the NASCI annual meeting.
- An author can be the presenting author on no more than two (2) submissions.
- The majority of accepted presentations will be in the form of in-person slide presentations at a kiosk during moderated posters sessions.
- Select presentations will be invited for oral podium presentations in the general session of the conference.
- Scientific abstracts from trainees will be considered for the Dr. Joe Schoepf Young Investigator Awards. If selected, they will be invited for a podium presentation during the Dr. Joe Schoepf Young Investigator Session of the Annual meeting. Winners and prizes will be determined at that time and announced at the annual business meeting. The competition presenters must plan to be present and available at the meeting through the end of the annual business meeting.
- Word Count: The maximum word count is 300 words not including Title and authors.
- Two types of abstracts will be accepted:
Educational (scholarly analysis of a specific topic reported in the literature)
– educational abstracts will consist of 4 submission sections – purpose, major teaching points, content outline, conclusion
Scientific (hypothesis-driven research with results and discussion)
– scientific abstracts will consist of 5 submission sections – purpose, methods, results, conclusion, clinical significanceAbstract Submission Categories
| Adult Congenital Heart Disease |
| Cardiothoracic Complications Related to Cancer Therapeutic Agents |
| Cardiothoracic Infection |
| Cardiothoracic Inflammatory Conditions |
| Cardiovascular Disease in Women |
| Cardiovascular Emergencies and Trauma |
| Cutting Edge Technology/State of the Art Imaging |
| Guidelines and Trials and Their Impact on Clinical Practice |
| Health Disparities in Cardiovascular Disease |
| Heart Transplantation: Pre and Post Imaging and Complications |
| Imaging to Guide Interventions |
| Ischemic Heart disease |
| Non-ischemic Cardiomyopathies |
| Pediatric Cardiac Imaging |
| Structural Heart Disease |
| Other |
- Disclosures for ALL authors/co-authors is required within the submission form as well as their institutions, city, state, etc. (have this information prior to starting your submission).
- Please note that presenting at the NASCI annual course does not disqualify individuals from submitting the same abstract for consideration at RSNA.